4/A
Changes in Ownership
Entrada Therapeutics, Inc. Filed Acc 0001689375-23-000030
President and CEO acquired 49,650 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Doshi Dipal President and CEO | 2023-03-01 | Grant or award | +49,650 | 206,161 | D | ||
| Derivatives | |||||||
| Doshi Dipal President and CEO | 2023-03-01 | Grant or award · Stock Option (Right to Buy) | +75,250 | 75,250 | D | ||
Loading xslF345X04/wf-form4a_168194111990641.xml…